tradingkey.logo

Bionano Genomics Inc

BNGO
1.600USD
+0.010+0.63%
收盘 12/19, 16:00美东报价延迟15分钟
15.57M总市值
亏损市盈率 TTM

Bionano Genomics Inc

1.600
+0.010+0.63%

关于 Bionano Genomics Inc 公司

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc简介

公司代码BNGO
公司名称Bionano Genomics Inc
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)
员工数量98
证券类型Ordinary Share
年结日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92121
电话18588887600
网址https://bionano.com/
公司代码BNGO
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)

Bionano Genomics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%
地区USD
名称
营收
占比
EMEIA
3.23M
47.94%
Americas
2.93M
43.46%
Asia Pacific
579.00K
8.60%
业务
地区
业务USD
名称
营收
占比
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%

股东统计

更新时间: 12月4日 周四
更新时间: 12月4日 周四
持股股东
股东类型
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
UBS Financial Services, Inc.
0.62%
其他
84.47%
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
UBS Financial Services, Inc.
0.62%
其他
84.47%
股东类型
持股股东
占比
Investment Advisor
6.44%
Corporation
5.16%
Individual Investor
3.19%
Hedge Fund
2.07%
Investment Advisor/Hedge Fund
0.37%
Research Firm
0.10%
其他
82.67%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Lincoln Alternative Strategies LLC
525.00K
5.42%
+525.00K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.91%
+475.00K
--
Sep 16, 2025
Abbe (Richard)
157.50K
1.63%
+157.50K
--
Sep 16, 2025
Iroquois Capital Management, LLC
367.50K
3.8%
+367.50K
--
Sep 16, 2025
UBS Financial Services, Inc.
2.31K
0.02%
+397.00
+20.79%
Jun 30, 2025
Geode Capital Management, L.L.C.
18.87K
0.19%
+3.37K
+21.70%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
公告日期
类型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1

常见问题

Bionano Genomics Inc的前五大股东是谁?

Bionano Genomics Inc 的前五大股东如下:
Lincoln Alternative Strategies LLC持有股份:525.00K,占总股份比例:5.42%。
Heights Capital Management, Inc.持有股份:475.00K,占总股份比例:4.91%。
Abbe (Richard)持有股份:157.50K,占总股份比例:1.63%。
Iroquois Capital Management, LLC持有股份:367.50K,占总股份比例:3.80%。
UBS Financial Services, Inc.持有股份:2.31K,占总股份比例:0.02%。

Bionano Genomics Inc的前三大股东类型是什么?

Bionano Genomics Inc 的前三大股东类型分别是:
Lincoln Alternative Strategies LLC
Heights Capital Management, Inc.
Abbe (Richard)

有多少机构持有Bionano Genomics Inc(BNGO)的股份?

截至2025Q4,共有123家机构持有Bionano Genomics Inc的股份,合计持有的股份价值约为914.11K,占公司总股份的2.31%。与2025Q3相比,机构持股有所增加,增幅为-0.26%。

哪个业务部门对Bionano Genomics Inc的收入贡献最大?

在FY2025Q2,Consumables业务部门对Bionano Genomics Inc的收入贡献最大,创收3.28M,占总收入的48.66%。
KeyAI